stockrow
Tuesday 3 November 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
66.49
1.96
−2.86%
Follow CNC
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 9.66 | 15.58 | 38.34 | 35.67 | 19.24 | 19.71 | 24.32 | 21.38 | 18.06 |
Piotroski F-Score |
5 | 5 | 8 | 7 | 5 | 5 | 5 | 5 | 4 | 4 |
Altman Z-Score |
2.64 | 2.76 | 2.60 | 2.67 | 2.43 | 2.41 | 2.90 | 2.95 | 3.23 | 2.71 |
P/S ratio |
0.10 | 0.19 | 0.27 | 0.32 | 0.38 | 0.31 | 0.35 | 0.37 | 0.37 | 0.23 |
P/FCF ratio |
4.70 | 0.00 | 5.75 | 8.72 | 14.58 | 7.39 | 34.52 | 40.25 | 16.58 | 6.02 |
Altman Z″-Score (non-manufacturers) |
0.39 | 1.66 | 1.47 | 1.14 | 1.27 | 1.43 | 2.34 | 1.29 | 1.07 | 1.08 |
Beneish M-Score |
(3.07) | (1.99) | (2.70) | (2.79) | (2.31) | (2.16) | (2.29) | (2.18) | (2.47) | (1.70) |
P/Operating CF |
46.43 | (53.85) | 192.37 | (29.10) | 71.15 | 11.49 | (39.93) | (35.49) | 39.31 | 5.85 |
P/B ratio |
1.01 | 1.19 | 1.61 | 1.90 | 1.78 | 1.32 | 2.05 | 2.04 | 2.58 | 1.57 |
Price to Tangible BV |
4.35 | 8.95 | 18.32 | 0.00 | 0.00 | 0.00 | 6.96 | 12.79 | 24.67 | 0.00 |
EV/Sales |
0.09 | 0.21 | 0.26 | 0.34 | 0.41 | 0.35 | 0.36 | 0.38 | 0.37 | 0.23 |
EV/EBITDA |
0.00 | 7.58 | 9.45 | 18.01 | 16.74 | 8.91 | 11.03 | 11.84 | 11.40 | 6.18 |
EV/Operating CF |
3.41 | 217.26 | 4.96 | 7.90 | 12.42 | 7.03 | 18.03 | 18.74 | 11.95 | 5.15 |
EV/FCF |
4.02 | (68.28) | 5.50 | 9.41 | 15.84 | 8.34 | 35.51 | 41.36 | 16.67 | 6.17 |
Quick Ratio |
1.05 | 1.06 | 0.96 | 0.97 | 1.04 | 1.02 | 1.49 | 0.94 | 0.86 | 0.89 |
Current Ratio |
1.10 | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 | 0.97 |
Net Debt/EBITDA |
0.46 | 0.42 | (0.43) | 1.32 | 1.34 | 1.01 | 0.31 | 0.32 | 0.06 | 0.14 |
Debt/Assets |
22.67% | 22.48% | 21.06% | 23.44% | 24.04% | 24.42% | 33.48% | 21.64% | 21.50% | 23.05% |
Debt/Equity |
0.87 | 0.70 | 0.69 | 0.75 | 0.70 | 0.65 | 1.08 | 0.61 | 0.68 | 0.79 |
Asset Turnover |
2.45 | 1.95 | 1.91 | 1.86 | 1.71 | 2.03 | 2.08 | 2.28 | 2.30 | 2.95 |
Operating CF/Net income |
(0.76) | 0.05 | 2.98 | 5.21 | 3.12 | 3.04 | 1.12 | 1.37 | 1.80 | 3.29 |
Capex/Depreciation |
(0.60) | (0.52) | (0.62) | (0.70) | (0.68) | (0.69) | (1.14) | (1.36) | (1.17) | (1.10) |
Interest Coverage |
(11.24) | 4.52 | 4.04 | 1.98 | 2.68 | 4.23 | 4.32 | 4.25 | 4.70 | 5.82 |
| (28.69%) | 12.61% | 10.78% | 4.70% | 5.10% | 9.38% | 11.16% | 10.07% | 12.96% | 13.92% | |
| (8.38%) | 3.96% | 3.35% | 1.55% | 1.83% | 3.30% | 3.67% | 3.41% | 3.94% | 4.08% | |
ROIC |
(27.84%) | 7.00% | 7.59% | 2.96% | 3.58% | 6.36% | 8.31% | 7.83% | 10.77% | 12.88% |
Return on Tangible Assets |
(116.86%) | 56.93% | 44.59% | 29.35% | 22.00% | 39.46% | 13.89% | 51.93% | 174.32% | 104.27% |
Average Days of Receivables |
33.93 | 44.12 | 36.81 | 33.51 | 35.46 | 31.85 | 30.55 | 31.27 | 25.75 | 28.90 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
6.63% | 7.60% | 8.16% | 8.02% | 7.62% | 8.44% | 8.75% | 10.05% | 9.19% | 9.05% |
Intangible Assets out of Total Assets |
0.20 | 0.28 | 0.28 | 0.33 | 0.35 | 0.39 | 0.22 | 0.30 | 0.28 | 0.31 |
Share Based Compensation of Revenue |
0.10% | 0.13% | 0.14% | 0.16% | 0.16% | 0.25% | 0.24% | 0.24% | 0.28% | 0.36% |
Graham Net Nets |
(0.81) | (0.57) | (0.43) | (0.49) | (0.48) | (0.57) | (0.31) | (0.35) | (0.36) | (0.64) |
Graham Number |
0.00 | 84.64 | 72.77 | 44.36 | 49.01 | 56.43 | 46.88 | 38.79 | 32.78 | 25.94 |
Earnings Yield |
(33.07%) | 10.35% | 6.42% | 2.61% | 2.80% | 5.20% | 5.07% | 4.11% | 4.68% | 5.54% |
Free Cash Flow Yield |
21.29% | (1.55%) | 17.38% | 11.46% | 6.86% | 13.53% | 2.90% | 2.48% | 6.03% | 16.60% |
Revenue per Share |
394.99 | 312.52 | 283.44 | 251.30 | 216.15 | 194.69 | 180.51 | 154.05 | 140.30 | 127.24 |
Operating CF per Share |
10.32 | 0.30 | 14.82 | 10.89 | 7.21 | 9.64 | 3.59 | 3.16 | 4.32 | 5.80 |
Capex per Share |
(1.56) | (1.23) | (1.47) | (1.75) | (1.56) | (1.52) | (1.77) | (1.73) | (1.22) | (0.96) |
Free Cash Flow per Share |
8.76 | (0.94) | 13.35 | 9.14 | 5.65 | 8.12 | 1.82 | 1.43 | 3.09 | 4.84 |
Cash per Share |
41.21 | 31.98 | 36.17 | 25.03 | 25.15 | 21.69 | 31.41 | 15.54 | 13.35 | 13.90 |
Shareholders Equity per Share |
40.63 | 50.79 | 47.74 | 42.04 | 46.22 | 45.35 | 30.62 | 28.22 | 19.90 | 18.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
40.63 | 50.79 | 47.74 | 42.04 | 46.22 | 45.35 | 30.62 | 28.22 | 19.90 | 18.52 |
Free Cash Flow |
4,321.00 | (490.00) | 7,254.00 | 5,257.00 | 3,295.00 | 4,634.00 | 753.00 | 559.00 | 1,067.00 | 1,545.00 |
Working Capital |
3,674.00 | 3,738.00 | 4,040.00 | 1,664.00 | 2,732.00 | 1,808.00 | 7,391.00 | 27.00 | (629.00) | (258.00) |
Capital Expenditures |
(767.00) | (644.00) | (799.00) | (1,004.00) | (910.00) | (869.00) | (730.00) | (675.00) | (422.00) | (306.00) |
Net Current Asset Value |
(16,344.00) | (17,946.00) | (17,948.00) | (22,561.00) | (22,938.00) | (19,441.00) | (8,012.00) | (7,890.00) | (6,288.00) | (5,923.00) |
EV/EBIT |
0.00 | 10.54 | 13.62 | 37.55 | 29.26 | 12.54 | 15.01 | 15.86 | 14.83 | 7.54 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 9.96 | 14.25 | 34.80 | 26.92 | 11.12 | 14.60 | 15.43 | 14.75 | 7.37 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.63 | 0.60 | 0.64 | 0.59 | 0.39 | 0.45 | 0.30 | 0.29 | 0.33 | 0.35 |
Cash ROIC |
7.48% | (0.79%) | 11.44% | 9.29% | 5.45% | 8.42% | 1.91% | 2.35% | 6.60% | 10.30% |
Accounts Receivable Turnover |
10.30 | 9.25 | 10.69 | 11.33 | 11.49 | 13.94 | 13.10 | 14.04 | 14.60 | 18.07 |
Accounts Payable Turnover |
13.43 | 9.88 | 10.54 | 14.20 | 14.37 | 17.07 | 16.02 | 12.58 | 10.74 | 14.80 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
27.79 | 32.88 | 43.85 | 27.18 | 27.73 | 26.91 | 23.10 | 28.60 | 35.70 | 39.17 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
18,909.00 | 17,622.50 | 14,402.00 | 12,755.00 | 10,967.00 | 7,971.50 | 5,698.50 | 4,281.50 | 3,314.00 | 2,247.00 |
Average Payables |
13,474.00 | 14,797.00 | 12,972.50 | 9,009.00 | 7,781.00 | 5,616.50 | 4,107.50 | 4,108.00 | 3,964.00 | 2,369.50 |
Average Assets |
79,596.00 | 83,543.00 | 80,755.50 | 77,622.50 | 73,547.00 | 54,856.50 | 35,947.50 | 26,378.00 | 21,026.00 | 13,768.00 |
Average Common Equity |
23,266.50 | 26,218.50 | 25,059.00 | 25,560.50 | 26,412.50 | 19,272.00 | 11,836.00 | 8,938.50 | 6,386.50 | 4,038.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026